Warner Chilcott plc
News and overview for Warner Chilcott plc
Warner Chilcott prices secondary offering of 20 million shares at $22.25 per share
Sun (Baltimore), The | 4 days 5 hours 9 minutes ago
Warner Chilcott PLC, which makes women's health and dermatology products, said a secondary offering of 20 million shares priced at $22.25 per share.
Warner Chilcott prices secondary offering of 20 million shares at $22.25 per share -- South Florida Sun-Sentinel.com
Sun-Sentinel (Fort Lauderdale, Fla.) | 4 days 6 hours 8 minutes ago
NEW YORK (AP) — Warner Chilcott PLC, which makes women's health and dermatology products, said a secondary offering of 20 million shares priced at $22.25 per share.
Warner Chilcott reports a net income of $424.2M for the quarter ended September 30, 2009
News-Medical.Net | 15 days 7 hours 9 minutes ago
Warner Chilcott plc (Nasdaq: WCRX) today announced its results for the quarter ended September 30, 2009. Revenue in the quarter ended September 30, 2009 increased 9.0% to $252.8 million over the prior year quarter. The primary drivers of the increase in revenue in the quarter were the net sales of LOESTRIN 24 FE and ESTRACE Cream which were partially offset by net sales declines of other products, primarily TACLONEX.
Warner Chilcott to offer 20,000,000 shares in secondary offering
News-Medical.Net | 11 days 7 hours 1 minute ago
Warner Chilcott plc (Nasdaq: WCRX) today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders
P&G's global branded prescription pharmaceutical business acquired by Warner Chilcott
News-Medical.Net | 25 days 6 hours 8 minutes ago
Warner Chilcott plc (Nasdaq: WCRX) announced today it has completed the acquisition of The Procter & Gamble Company's global branded prescription pharmaceutical business. The acquisition complements Warner Chilcott's existing presence in women's health care and adds new therapeutic and geographic markets. At closing approximately 1,900 employees of P&G's pharmaceuticals business joined Warner Chilcott and the Company added manufacturing facilities in Germany and Puerto Rico.
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2009 [Press Release]
PRNewswire | 15 days 2 hours 28 minutes ago
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2009...Nov. 9 ARDEE, Ireland, Nov. 9 /PRNewswire-FirstCall/ -- Warner Chilcott plc today announced its results for the quarter ended September 30, 2009...
LEO Pharma Repurchases Product Rights From Warner Chilcott [Press Release]
PRNewswire | 62 days 7 hours 54 minutes ago
...Sept. 23 /PRNewswire-FirstCall/ -- Warner Chilcott plc and LEO Pharma announced today that, in...President and Chief Executive Officer of Warner Chilcott plc. "This transaction allows Warner Chilcott to concentrate on new strategic...
Warner Chilcott Prices Secondary Equity Offering [Press Release]
PRNewswire | 4 days 13 hours 12 minutes ago
...Nov. 19 /PRNewswire/ -- Warner Chilcott plc today announced the pricing of...telephone at 1-718-242-8002. Warner Chilcott is a leading specialty...Fuhrmann, Investor Relations of Warner Chilcott plc,+1-973-442-3281, rfuhrmann...
Warner Chilcott Acquires P&G's Global Pharmaceuticals Business [Press Release]
PRNewswire | 92 days 7 hours 56 minutes ago
...FirstCall/ -- The Procter & Gamble Company and Warner Chilcott plc today announced an agreement for the sale of P&G's global pharmaceuticals business to Warner Chilcott for an up-front cash payment of $3.1 billion...
Warner Chilcott Completes Irish Redomestication [Press Release]
PRNewswire | 95 days 8 hours 26 minutes ago
...value $0.01 per share, of Warner Chilcott plc on a one-for-one basis...wholly owned subsidiary of Warner Chilcott plc, a newly formed public limited...resident of, Ireland. Shares of Warner Chilcott plc will begin trading on the NASDAQ...
Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2009 Financial Results [Press Release]
PRNewswire | 21 days 17 hours 13 minutes ago
Warner Chilcott Announces Earnings Release Date and...2 /PRNewswire-FirstCall/ -- Warner Chilcott plc announced today that it will issue...Fuhrmann, Investor Relations, of Warner Chilcott plc,+1-973-442-3281, rfuhrmann...
Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance [Press Release]
PRNewswire | 109 days 9 hours 27 minutes ago
...transaction will result in Warner Chilcott plc, a newly formed public holding...the transaction, shares of Warner Chilcott plc will begin trading on the NASDAQ...of distributable reserves of Warner Chilcott plc, subject to the approval of...
Warner Chilcott Completes Acquisition of P&G's Global Branded Prescription Pharmaceuticals Business [Press Release]
PRNewswire | 25 days 2 hours 28 minutes ago
...Ireland, Oct. 30 /PRNewswire-FirstCall/ -- Warner Chilcott plc announced today it has completed the acquisition...pharmaceutical business. The acquisition complements Warner Chilcott's existing presence in women's health care and...
Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development [Press Release]
PRNewswire | 34 days 18 hours 58 minutes ago
...Ireland, Oct. 20 /PRNewswire-FirstCall/ -- Warner Chilcott plc announced today that Dr. Mahdi Fawzi has joined...President, Global Research and Development. He joins Warner Chilcott from Wyeth Pharmaceuticals, where he was responsible...
Warner Chilcott Announces Shareholder Approval of Irish Redomestication [Press Release]
PRNewswire | 110 days 23 hours 55 minutes ago
...transaction will result in Warner Chilcott plc, a newly formed public limited...shares of the Irish company, Warner Chilcott plc, will begin trading on the...of distributable reserves of Warner Chilcott plc, subject to the approval of...
Sign up for SmartBrief on Entrepreneurs
Company Overview
| Company: | Warner Chilcott plc |
|---|---|
| Industry: | Pharmaceuticals Manufacturers |
| Website: | http://www.warnerchilcott.com |
Warner Chilcott has a long commute. Though it's domiciled in Ireland, the pharmaceutical manufacturer works mainly in the US, selling brand-name drugs to the country's OB/GYNs and dermatologists. For women, Warner Chilcott makes and markets hormonal contraceptives (including Femcon FE, Loestrin, and Ovcon) and hormone therapies, such as Estrace cream and femhrt. In the area of dermatology, the specialty drug firm makes an acne drug called Doryx. Warner Chilcott has manufacturing facilities in the US, Puerto Rico, and Ireland.
Key Numbers
| Sales in U.S. Dollars (mil.) | 938.1 (2008) |
|---|---|
| One-year % Growth in Sales | 4.3 (2008) |
| Net Income in U.S. Dollars (mil.) | -8.4 (2008) |
| One-year % Growth in Net Income | 0.0 (2008) |
| Number of Employees | 1,115 (2008) |
| One-year % Growth in Number of Employees | -0.9 (2008) |
| Fiscal Year-End | December |